What is Hapten Sciences?
Hapten Sciences is a privately held biopharmaceutical entity headquartered in Memphis, Tennessee. The company is dedicated to the identification and development of novel, early-stage products with the overarching mission to substantially improve global health and well-being. Through its innovative research and development strategies, Hapten Sciences aims to make a significant positive impact on the biopharmaceutical sector, offering advanced therapeutic solutions to healthcare providers and patients alike. The company's focus on early-stage product development positions it as a key player in advancing medical treatments.
How much funding has Hapten Sciences raised?
Hapten Sciences has raised a total of $3M across 3 funding rounds:
Private Equity
$625K
Debt
$1.2M
Debt
$1.2M
Private Equity (2013): $625K with participation from MB Venture Partners
Debt (2015): $1.2M, investors not publicly disclosed
Debt (2017): $1.2M supported by MB Venture Partners
Key Investors in Hapten Sciences
MB Venture Partners
MB Venture Partners is a Memphis-based venture capital firm specializing in capital and strategic direction for life science companies, particularly in the medical device sector. They invest across all stages of start-up development, with a focus on musculoskeletal disease solutions. MBVP has a history of backing successful ventures, with notable acquisitions by major corporations.
What's next for Hapten Sciences?
The recent major strategic investment signifies a pivotal moment for Hapten Sciences, likely enabling the company to accelerate its product development pipeline, expand its research capabilities, and potentially scale its operations. Given the enterprise-level funding context, Hapten Sciences is poised for significant growth, possibly moving towards later-stage clinical trials or market entry for its novel biopharmaceutical products. This strategic backing from investors suggests confidence in the company's long-term vision and its capacity to deliver impactful healthcare solutions.
See full Hapten Sciences company page
